IBO — IMPACT BIOMEDICAL INC
What is a 13F filing? Who files one and when · What 13F filings can't tell you
Fundamentals (SEC EDGAR XBRL)
Financials from SEC company facts, point-in-time aligned to each figure’s EDGAR filing date.
| Revenue TTM | Revenue YoY | Net income TTM | Net income YoY | ROE (TTM) | Gross margin | Net margin | P/E (TTM) | P/E pct | P/B | P/B pct |
|---|---|---|---|---|---|---|---|---|---|---|
| $49,000 | — | -$5.1M | — | -50.4% | — | -3071.4% | — | — | — | — |
Revenue YoY trend Net margin trend
Last updated: 2026-11-21 · Source: SEC EDGAR Form 13F-HR
As of Q3 2026, 17 SEC-registered investment managers reported holding IBO (IMPACT BIOMEDICAL INC) in their latest 13F filings, with a combined reported value of $1.71M across 305.61K shares. That is -91.8% by share count (-2.87M shares) versus the previous quarter, while reported value moved +0.1%. Ownership is concentrated: the five largest holders account for 92.6% of reported value and the top ten for 100.0%.
Compared with the prior quarter, 2 opened new positions, 1 added to existing stakes, 14 trimmed, 6 exited entirely. 13F holdings are quarter-end snapshots, so these moves reflect positioning as of Q3 2026, not real-time trading.
Major shareholders of IMPACT BIOMEDICAL INC (IBO) include GEODE CAPITAL MANAGEMENT, LLC, Geode Capital Management, VANGUARD CAPITAL MANAGEMENT LLC, ranked by reported 13F value among the 39 institutional holders on this page.
IBO is classified in the Health Care sector.
All figures on this page are computed from SEC Form 13F quarterly filings. 13F filers disclose long positions of $100,000 or more within 45 days of quarter end; short positions, options overlays and intra-quarter trades are not included, so treat the numbers as a quarterly snapshot of institutional ownership rather than real-time positioning.
Institutional Ownership by Quarter
| Quarter | Funds holding | Shares | Value | QoQ Net Change |
|---|---|---|---|---|
| Q3 2026 | 17 | 305.61K | $1.71M | -91.8% |
| Q2 2026 | 20 | 4.41M | $2.03M | +1.2% |
| Q1 2026 | 20 | 3.72M | $2.23M | +472.7% |
| Q4 2025 | 24 | 1.58M | $795.98K | +134.8% |
| Q3 2025 | 20 | 538.40K | $357.96K | +8.9% |
| Q2 2025 | 19 | 508.04K | $328.21K | +36.9% |
| Q1 2025 | 17 | 404.03K | $351.20K | +39.8% |
| Q4 2024 | 10 | 52.69K | $76.13K | +63.4% |
Over the 8 quarters shown, institutional share counts increased 480% in aggregate (Q4 2024 → Q3 2026); the largest single-quarter swing was Q1 2026 (+472.7%).
Top Institutional Holders (Q3 2026) — 17 funds
| Fund | Shares | Value | Portfolio Weight | Change |
|---|---|---|---|---|
| 93.92K | $526.32K | 0.00% | Reduce | |
| 73.75K | $413.03K | 0.00% | Reduce | |
| 48.71K | $272.78K | 0.00% | Reduce | |
| 46.71K | $261.55K | 0.00% | Reduce | |
| 20.02K | $112.13K | 0.00% | Reduce | |
| 18.66K | $104.48K | 0.00% | Reduce | |
| 2.55K | $14.29K | 0.00% | Reduce | |
| 738 | $4.13K | 0.00% | Reduce | |
| 299 | $1.67K | 0.00% | Reduce | |
| 144 | $806 | 0.00% | Reduce | |
| 59 | $330 | 0.00% | Reduce | |
| 22 | $123 | 0.00% | Reduce | |
| 17 | $95 | 0.00% | Reduce | |
| 4 | $22 | 0.00% | Add | |
| 2 | $11 | 0.00% | Reduce | |
| 2 | $11 | 0.00% | New | |
| 2 | $11 | 0.00% | New |
Holder history for earlier quarters, one table per quarter: Back to the Top 25 holders
Q2 2026 — 20 funds
| Fund | Shares | Value | Portfolio Weight | Change |
|---|---|---|---|---|
| 1.19M | $545.58K | 0.00% | New | |
| 1.19M | $545.58K | 0.00% | Reduce | |
| 808.69K | $372.00K | 0.00% | Add | |
| 589.43K | $271.14K | 0.00% | Add | |
| 259.95K | $119.58K | 0.00% | Hold | |
| 235.47K | $108.32K | 0.00% | Reduce | |
| 49.57K | $22.80K | 0.00% | New | |
| 32.20K | $14.81K | 0.00% | Hold | |
| 24.53K | $11.28K | 0.00% | New | |
| 17.19K | $7.91K | 0.00% | Reduce | |
| 10.00K | $4.60K | 0.00% | Hold | |
| 9.29K | $4.27K | 0.00% | Hold | |
| 2.40K | $1.10K | 0.00% | Reduce | |
| 1.82K | $836 | 0.00% | Hold | |
| 292 | $134 | 0.00% | Add | |
| 224 | $103 | 0.00% | Hold | |
| 218 | $100 | 0.00% | Hold | |
| 86 | $40 | 0.00% | Hold | |
| 27 | $12 | 0.00% | Hold | |
| 3 | $1 | 0.00% | Hold |
Q1 2026 — 20 funds
| Fund | Shares | Value | Portfolio Weight | Change |
|---|---|---|---|---|
| 1.19M | $716.25K | 0.00% | Add | |
| 708.17K | $424.90K | 0.00% | New | |
| 607.90K | $364.74K | 0.00% | Add | |
| 585.20K | $351.12K | 0.00% | New | |
| 259.95K | $155.97K | 0.00% | Hold | |
| 243.94K | $146.37K | 0.00% | Add | |
| 37.43K | $22.46K | 0.00% | Reduce | |
| 32.42K | $19.45K | 0.00% | Add | |
| 32.20K | $19.32K | 0.00% | New | |
| 10.00K | $5.85K | 0.00% | Hold | |
| 9.27K | $5.56K | 0.00% | Hold | |
| 1.82K | $1.09K | 0.00% | New | |
| 353 | $212 | 0.00% | Add | |
| 290 | $174 | 0.00% | New | |
| 224 | $134 | 0.00% | Hold | |
| 218 | $131 | 0.00% | Hold | |
| 86 | $52 | 0.00% | Hold | |
| 28 | $17 | 0.00% | New | |
| 27 | $16 | 0.00% | New | |
| 3 | $2 | 0.00% | Hold |
Q4 2025 — 24 funds
| Fund | Shares | Value | Portfolio Weight | Change |
|---|---|---|---|---|
| 814.88K | $411.52K | 0.00% | Add | |
| 259.95K | $131.27K | 0.00% | Add | |
| 137.82K | $69.60K | 0.00% | New | |
| 137.82K | $69.60K | 0.00% | New | |
| 74.38K | $37.56K | 0.00% | Add | |
| 39.83K | $20.11K | 0.00% | Add | |
| 22.70K | $11.46K | 0.00% | Reduce | |
| 16.50K | $8.33K | 0.00% | Reduce | |
| 14.09K | $7.11K | 0.00% | New | |
| 13.53K | $6.00K | 0.00% | New | |
| 11.80K | $5.96K | 0.00% | Hold | |
| 10.22K | $5.16K | 0.00% | New | |
| 10.00K | $5.05K | 0.00% | Hold | |
| 9.27K | $4.68K | 0.00% | Hold | |
| 2.17K | $1.09K | 0.00% | Reduce | |
| 1.43K | $720 | 0.00% | Reduce | |
| 924 | $467 | 0.00% | Add | |
| 224 | $113 | 0.00% | Reduce | |
| 218 | $110 | 0.00% | Hold | |
| 86 | $43 | 0.00% | Hold | |
| 3 | $2 | 0.00% | Hold | |
| 4 | $2 | 0.00% | Hold | |
| 1 | $1 | 0.00% | Reduce | |
| 1 | $1 | 0.00% | Hold |
Q3 2025 — 20 funds
| Fund | Shares | Value | Portfolio Weight | Change |
|---|---|---|---|---|
| 252.73K | $168.01K | 0.00% | Hold | |
| 102.91K | $68.43K | 0.00% | Add | |
| 45.11K | $29.99K | 0.00% | Reduce | |
| 31.50K | $20.94K | 0.00% | Add | |
| 28.44K | $18.91K | 0.00% | New | |
| 20.96K | $13.94K | 0.00% | Reduce | |
| 20.09K | $13.36K | 0.00% | Reduce | |
| 11.80K | $7.84K | 0.00% | Hold | |
| 10.00K | $6.65K | 0.00% | New | |
| 9.27K | $6.16K | 0.00% | New | |
| 3.40K | $2.26K | 0.00% | Reduce | |
| 1.44K | $959 | 0.00% | Hold | |
| 253 | $168 | 0.00% | Add | |
| 218 | $145 | 0.00% | New | |
| 168 | $111 | 0.00% | Add | |
| 86 | $57 | 0.00% | Hold | |
| 36 | $24 | 0.00% | Hold | |
| 4 | $3 | 0.00% | Hold | |
| 3 | $2 | 0.00% | Hold | |
| 1 | $1 | 0.00% | Hold |
Q2 2025 — 19 funds
| Fund | Shares | Value | Portfolio Weight | Change |
|---|---|---|---|---|
| 252.73K | $163.57K | 0.00% | Add | |
| 49.87K | $32.27K | 0.00% | Add | |
| 39.73K | $25.70K | 0.00% | Add | |
| 36.36K | $23.64K | 0.00% | Hold | |
| 32.44K | $20.99K | 0.00% | Reduce | |
| 30.82K | $19.95K | 0.00% | New | |
| 22.70K | $14.69K | 0.00% | New | |
| 11.80K | $7.63K | 0.00% | Hold | |
| 10.79K | $6.99K | 0.00% | New | |
| 10.33K | $6.00K | 0.00% | Reduce | |
| 8.78K | $5.68K | 0.00% | New | |
| 1.45K | $938 | 0.00% | Reduce | |
| 86 | $56 | 0.00% | Hold | |
| 80 | $52 | 0.00% | Add | |
| 36 | $23 | 0.00% | New | |
| 29 | $19 | 0.00% | Reduce | |
| 4 | $3 | 0.00% | Hold | |
| 3 | $2 | 0.00% | Hold | |
| 1 | $1 | 0.00% | Hold |
New Positions (Q3 2026)
- Citigroup Inc 2 sh · $11
- Robinhood Markets, Inc. 2 sh · $11
Fully Exited (vs previous quarter)
- GEODE CAPITAL MANAGEMENT, LLC sold 1.19M sh · $545.58K
- Citadel Advisors sold 49.57K sh · $22.80K
- JANE STREET GROUP, LLC sold 24.53K sh · $11.28K
- Two Sigma Investments sold 17.19K sh · $7.91K
- Mason & Associates Inc sold 10.00K sh · $4.60K
- NFSG Corp sold 86 sh · $40
Fund Position History — shares by quarter (top 20 funds)
| Fund | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 |
|---|---|---|---|---|---|---|---|---|---|
| Geode Capital Management | 93.92K | 1.19M | 1.19M | 74.38K | 45.11K | 49.87K | 23.20K | 20.77K | — |
| VANGUARD CAPITAL MANAGEMENT LLC | 73.75K | 808.69K | 708.17K | — | — | — | — | — | — |
| STATE STREET CORP | 48.71K | — | 607.90K | 11.80K | 11.80K | 11.80K | 11.80K | 11.17K | — |
| VANGUARD FIDUCIARY TRUST CO | 46.71K | 589.43K | 585.20K | — | — | — | — | — | — |
| BlackRock Inc | 20.02K | 259.95K | 259.95K | 259.95K | 252.73K | 252.73K | 30.68K | — | — |
| Northern Trust Corp | 18.66K | 235.47K | 243.94K | 10.22K | — | — | — | — | — |
| Vanguard Global Advisers, LLC | 2.55K | 32.20K | 32.20K | — | — | — | — | — | — |
| Morgan Stanley | 738 | 9.29K | 9.27K | 9.27K | 9.27K | — | 7.80K | — | 58 |
| UBS Group AG | 299 | 2.40K | 32.42K | 2.17K | 20.09K | 39.73K | 16.17K | 4.25K | 3 |
| Global Trust Asset Management, LLC | 144 | 1.82K | 1.82K | — | — | — | — | — | — |
| Wells Fargo & Co | 59 | 224 | 224 | 224 | 253 | 29 | 1.03K | 29 | 29 |
| Fidelity Management & Research (FMR) | 22 | 292 | 290 | — | 36 | 36 | — | — | — |
| BFC Planning, Inc. | 17 | 218 | 218 | 218 | 218 | — | — | — | — |
| DANSKE BANK A/S | 4 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 3 |
| Citigroup Inc | 2 | — | 353 | 1 | 3.40K | 8.78K | — | — | — |
| Burk Holdings LLC | 2 | 27 | 27 | — | — | — | — | — | — |
| Robinhood Markets, Inc. | 2 | — | — | — | — | — | — | — | — |
| GEODE CAPITAL MANAGEMENT, LLC | — | 1.19M | — | — | — | — | — | — | — |
| Vanguard Group | — | — | — | 814.88K | 102.91K | 32.44K | 126.45K | — | — |
| Millennium Management | — | — | — | 137.82K | — | — | — | — | — |
▲ Bought Low (fund opened/added, stock rose ≥5% next quarter) ▼ Sold High (fund reduced, stock fell ≥5% next quarter)
Drag / scroll to zoom · Default shows the most recent year · Annotations come from quarterly fund actions in 13F filings · Hover a marker for details
FAQ
Which funds hold IBO?
As of 2026-Q3, 17 institutional funds reported holding IBO (IMPACT BIOMEDICAL INC) in SEC 13F filings, with a combined reported value of $1.71M.
How many shares of IBO do institutions own?
13F filers reported 305.61K shares of IBO, worth $1.71M in aggregate at the end of 2026-Q3.
Is institutional ownership of IBO rising or falling?
Share counts moved -91.8% versus the prior quarter — distribution.
Who are the top institutional holders of IBO?
The largest 13F holders are GEODE CAPITAL MANAGEMENT, LLC, Geode Capital Management, VANGUARD CAPITAL MANAGEMENT LLC, Vanguard Group, STATE STREET CORP; the top 25 are ranked at the top of this page.
Who are the major shareholders of IMPACT BIOMEDICAL INC?
The major shareholders of IMPACT BIOMEDICAL INC (IBO) by reported 13F value are GEODE CAPITAL MANAGEMENT, LLC, Geode Capital Management, VANGUARD CAPITAL MANAGEMENT LLC, Vanguard Group, STATE STREET CORP, among 39 institutional holders.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.